Also called: AATD · Alpha-1 · Inherited emphysema
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Alpha-1 Antitrypsin Deficiency
Alpha-1 antitrypsin deficiency (AAT deficiency, or AATD) is an inherited condition that raises your risk for lung and liver disease. If you have this condition, your body doesn't make enough alpha-1 antitrypsin (AAT).
AAT is made by your liver. It helps protect your lungs from inflammation and irritating substances you might breathe in, such as smoke. If your liver doesn't make enough AAT, your lungs may be more easily damaged from smoking, pollution, or dust from the environment. This can lead to a serious lung condition called chronic obstructive pulmonary disease (COPD). AAT deficiency may also cause a liver disease called cirrhosis. This is more common in children who have AAT deficiency.
AAT deficiency is a genetic disorder. That means it's caused by changes in your genes, which may also be called gene variants or mutations.
Your genes carry information that controls what you look like and how your body works. AAT deficiency is caused by changes in the SERPINA1 gene, which carries instructions for making the AAT protein. These gene changes are inherited from your parents, so AAT deficiency tends to run in families:
- If you have two mutated copies of the gene, it means you have a condition called AAT deficiency. People with this disorder have a higher risk of getting lung disease or liver damage before the age of 45.
- If you have one mutated copy of the gene, you are a carrier of AAT deficiency. In these cases, this means you are at slightly higher risk of developing lung disease, especially if you have other risk factors, such as being a smoker. You could still pass the mutated gene on to your children.
There are a few gene changes that cause AAT deficiency. These gene changes can:
- Decrease the amount of AAT protein your liver makes.
- Prevent your liver from making any AAT.
- Affect the shape of the AAT protein so that it can't move out of your liver to protect your lungs. Over time, AAT builds up in your liver and causes damage.
Some people who have AAT deficiency do not have any symptoms. For those who do, symptoms usually appear in people between 20 and 50 years old. These symptoms may include:
- Wheezing
- Shortness of breath, especially after exercise
- Chronic cough with phlegm (mucus)
- Repeated respiratory infections such as colds and the flu
- Chest pain
- Fatigue
- Faster-than-normal heartbeat when you stand up
- Vision problems
- Losing weight without trying
Some people who have AAT deficiency may have liver damage. Signs of liver damage include jaundice (a condition that causes your skin and eyes to turn yellow) and swelling in your legs.
Rarely, AAT deficiency can cause skin problems, such as painful lumps or patches.
Your health care provider may test you for AAT deficiency if you have:
- Symptoms of AAT deficiency
- A condition that could be related to AAT deficiency
- Relatives who have AAT deficiency
- Relatives who have a lung or liver disease that could be related to AAT deficiency
AAT deficiency in babies often affects the liver. Your baby may need AAT testing if he or she has signs of liver disease such as jaundice or abnormal liver enzyme tests.
A blood test can check the level of AAT protein in your blood. If the level is lower than normal, it is likely that you have AAT deficiency.
A genetic test is the most certain way to check for AAT deficiency and should be done to confirm the results of the blood test. There are two types of genetic tests:
- A genotype test looks for the more common types of gene changes that can cause AAT deficiency.
- A phenotype test checks for changes in the AAT protein that change how it would normally work.
If your lungs are affected, you may also have lung function tests to see how well your lungs are working.
There is no cure for AAT deficiency, but there are treatments to help with the symptoms and slow the lung damage it causes. Treatment options may include:
- Inhaled medicines to help you breathe better.
- Pulmonary rehabilitation.
- Oxygen therapy.
- Augmentation therapy, which is a lifelong treatment. It raises the levels of the AAT protein in your lungs, using ATT protein taken from the blood of donors. It helps slow down lung damage. It cannot prevent liver damage.
- Lung surgery or a lung transplant, if your lungs are severely damaged.
- Liver transplant, if your liver is severely damaged.
To help prevent or delay lung damage, it is important to quit smoking (if you smoke) and avoid secondhand smoke, dust, and air pollution. Ask your provider If you need to stop drinking alcohol.
It sits within Lungs and Breathing and Genetics/Birth Defects.
The lead U.S. institute for this subject is the National Heart, Lung, and Blood Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Alpha-1 Antitrypsin Deficiency
144 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver ProblemsTakeda
- A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)AIRNA Corporation
- Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin DeficiencyUniversity Hospital, Bordeaux
- Role of Genetic Factors in the Development of Lung DiseaseNational Heart, Lung, and Blood Institute (NHLBI)
- A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)Tessera Therapeutics, Inc.
- IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel SyndromeAriel University
Research already completed
- A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)Wave Life Sciences USA, Inc.
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- Alpha-1 Antitrypsin DeficiencyNational Heart, Lung, and Blood Institute
- Learn about Alpha-1 Antitrypsin DeficiencyAmerican Lung Association
- Learning about Alpha-1 Antitrypsin Deficiency (AATD)National Human Genome Research Institute
Diagnosis and Tests
- Alpha-1 Antitrypsin TestingNational Library of Medicine
Genetics
- Alpha-1 antitrypsin deficiency: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: alpha 1-Antitrypsin DeficiencyNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under alpha 1-Antitrypsin Deficiency. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Alpha-1 Antitrypsin Deficiency, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.